IT8003429A0 - Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica - Google Patents

Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Info

Publication number
IT8003429A0
IT8003429A0 IT8003429A IT342980A IT8003429A0 IT 8003429 A0 IT8003429 A0 IT 8003429A0 IT 8003429 A IT8003429 A IT 8003429A IT 342980 A IT342980 A IT 342980A IT 8003429 A0 IT8003429 A0 IT 8003429A0
Authority
IT
Italy
Prior art keywords
riphamic
imidazo
substance
preparation
antibacterial action
Prior art date
Application number
IT8003429A
Other languages
English (en)
Other versions
IT1154655B (it
Inventor
Egidio Marchi Lauret Montecchi
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of IT8003429A0 publication Critical patent/IT8003429A0/it
Priority to IT03429/80A priority Critical patent/IT1154655B/it
Priority to NLAANVRAGE8102290,A priority patent/NL187022C/xx
Priority to US06/262,123 priority patent/US4341785A/en
Priority to AU70655/81A priority patent/AU537093B2/en
Priority to AT0222781A priority patent/AT373599B/de
Priority to GR65010A priority patent/GR75640B/el
Priority to LU83376A priority patent/LU83376A1/fr
Priority to FR8110058A priority patent/FR2482967A1/fr
Priority to PH25656A priority patent/PH17207A/en
Priority to EG280/81A priority patent/EG14891A/xx
Priority to PT73064A priority patent/PT73064B/pt
Priority to IE1139/81A priority patent/IE51204B1/en
Priority to FI811565A priority patent/FI69467C/fi
Priority to ZA00813430A priority patent/ZA813430B/xx
Priority to ES502906A priority patent/ES8203388A1/es
Priority to CA000378015A priority patent/CA1142518A/en
Priority to BE2/59169A priority patent/BE888895A/fr
Priority to NO811731A priority patent/NO155622C/no
Priority to DK224781A priority patent/DK157876C/da
Priority to SE8103216A priority patent/SE453089B/sv
Priority to DE19813120460 priority patent/DE3120460A1/de
Priority to AR285424A priority patent/AR226212A1/es
Priority to GB8115790A priority patent/GB2079270B/en
Priority to JP7787781A priority patent/JPS5711987A/ja
Priority to CH3381/81A priority patent/CH648037A5/de
Priority to PH26842A priority patent/PH18704A/en
Application granted granted Critical
Publication of IT1154655B publication Critical patent/IT1154655B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT03429/80A 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica IT1154655B (it)

Priority Applications (26)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
NLAANVRAGE8102290,A NL187022C (nl) 1980-05-22 1981-05-11 Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.
US06/262,123 US4341785A (en) 1980-05-22 1981-05-11 Imidazo-rifamycin derivatives with antibacterial utility
AU70655/81A AU537093B2 (en) 1980-05-22 1981-05-18 New imidazo-rifamycin derivatives with antibacterial utility
AT0222781A AT373599B (de) 1980-05-22 1981-05-19 Verfahren zur herstellung neuer rifamycinderivate
GR65010A GR75640B (it) 1980-05-22 1981-05-20
LU83376A LU83376A1 (fr) 1980-05-22 1981-05-20 Nouveaux derives d'imidazo-rifamycine a activite antibacterienne
FR8110058A FR2482967A1 (fr) 1980-05-22 1981-05-20 Nouveaux derives de l'imidazo-rifamycine, leur procede de preparation et leur application en therapeutique
PH25656A PH17207A (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with antibacterial utility
EG280/81A EG14891A (en) 1980-05-22 1981-05-20 A process for preparation of derivatives of imiadozo-new rifamicyn have process antibacterial utility
PT73064A PT73064B (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with anti-bacterial utility
FI811565A FI69467C (fi) 1980-05-22 1981-05-21 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrido- och isokinolin(1',2':1,2)imidazo(5,4-c)rifamycin soch sv-derivat
IE1139/81A IE51204B1 (en) 1980-05-22 1981-05-21 Imidazo-rifamycin derivatives
ZA00813430A ZA813430B (en) 1980-05-22 1981-05-21 New imidazo-rifamycin derivatives with antibacterial utility
ES502906A ES8203388A1 (es) 1980-05-22 1981-05-21 Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
CA000378015A CA1142518A (en) 1980-05-22 1981-05-21 Imidazo-rifamycin derivatives with antibacterial utility
BE2/59169A BE888895A (fr) 1980-05-22 1981-05-21 Nouveaux derives d'imidazo-rifamycine a activite antibacterienne
NO811731A NO155622C (no) 1980-05-22 1981-05-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido- og isokinolin (1[,2[:1,2) imidazo (5,4-c) rifamycin sv og s derivater.
DK224781A DK157876C (da) 1980-05-22 1981-05-21 Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
SE8103216A SE453089B (sv) 1980-05-22 1981-05-21 Imidazo-rifamycinderivat, forfarande for framstellning derav och farmaceutisk komposition
DE19813120460 DE3120460A1 (de) 1980-05-22 1981-05-22 Pyridoimidazolorifamycinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AR285424A AR226212A1 (es) 1980-05-22 1981-05-22 Procedimiento para preparar nuevos derivados de imidazo rifamicina
GB8115790A GB2079270B (en) 1980-05-22 1981-05-22 Imidazo-rifamycin derivatives
JP7787781A JPS5711987A (en) 1980-05-22 1981-05-22 Novel imidazo-rifamycin derivative
CH3381/81A CH648037A5 (de) 1980-05-22 1981-05-22 Imidazo-rifamycin-derivate mit antibakterieller wirksamkeit.
PH26842A PH18704A (en) 1980-05-22 1982-02-09 Method of treatment using inidazo-rifamycin derivatives with antibacterial utility

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (2)

Publication Number Publication Date
IT8003429A0 true IT8003429A0 (it) 1980-05-22
IT1154655B IT1154655B (it) 1987-01-21

Family

ID=11107198

Family Applications (1)

Application Number Title Priority Date Filing Date
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Country Status (25)

Country Link
US (1) US4341785A (it)
JP (1) JPS5711987A (it)
AR (1) AR226212A1 (it)
AT (1) AT373599B (it)
AU (1) AU537093B2 (it)
BE (1) BE888895A (it)
CA (1) CA1142518A (it)
CH (1) CH648037A5 (it)
DE (1) DE3120460A1 (it)
DK (1) DK157876C (it)
EG (1) EG14891A (it)
ES (1) ES8203388A1 (it)
FI (1) FI69467C (it)
FR (1) FR2482967A1 (it)
GB (1) GB2079270B (it)
GR (1) GR75640B (it)
IE (1) IE51204B1 (it)
IT (1) IT1154655B (it)
LU (1) LU83376A1 (it)
NL (1) NL187022C (it)
NO (1) NO155622C (it)
PH (2) PH17207A (it)
PT (1) PT73064B (it)
SE (1) SE453089B (it)
ZA (1) ZA813430B (it)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199374B (it) * 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
CA2230649C (en) * 1997-02-28 2007-11-06 Kaneka Corporation Medicine for a disease caused by infection of helicobacter
AU2002360416A1 (en) * 2001-11-21 2003-06-10 Activbiotics, Inc. Targeted therapeutics and uses thereof
US7078399B2 (en) * 2001-12-13 2006-07-18 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
ES2385477T3 (es) * 2002-11-05 2012-07-25 Fadim S.R.L. Liberación continua y controlada de rifaximina
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
EP1698630B1 (en) 2005-03-03 2014-09-03 ALFA WASSERMANN S.p.A. New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ITBO20050123A1 (it) * 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
AU2006339058B2 (en) 2005-08-11 2012-09-06 Targanta Therapeutics Inc. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
CN101594885B (zh) 2006-03-09 2017-07-18 萨利克斯药品公司 利福昔明抗直肠功能障碍制剂
CN104382900A (zh) 2006-08-02 2015-03-04 萨利克斯药品公司 治疗放射性肠炎的组合物和方法
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
WO2008035109A1 (en) * 2006-09-22 2008-03-27 Cipla Limited Rifaximin
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
AU2008273699A1 (en) 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
EP2837378A1 (en) 2007-07-06 2015-02-18 Lupin Limited Pharmaceutical compositions of rifaximin
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
US8486956B2 (en) * 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
JP5706693B2 (ja) 2008-02-25 2015-04-22 サリックス ファーマシューティカルズ リミテッド リファキシミンの型およびその使用
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
EP3563850A1 (en) 2008-02-26 2019-11-06 Salix Pharmaceuticals, Ltd. Methods for treating bowel diseases
WO2009137672A1 (en) 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
WO2010019511A2 (en) 2008-08-13 2010-02-18 Targanta Therapeutics Corp. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
JP5567484B2 (ja) 2008-09-26 2014-08-06 あすか製薬株式会社 機能性消化管障害の予防及び/又は治療剤
CA2739436C (en) 2008-10-02 2019-08-27 Salix Pharmaceuticals, Ltd. Use of rifaximin for treating hepatic encephalopathy
US8916193B2 (en) 2008-12-10 2014-12-23 Cipla Limited Rifaximin complexes
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
EP2437603A4 (en) 2009-06-02 2012-12-12 Salix Pharmaceuticals Ltd METHODS OF TREATING HEPATIC ENCEPHALOPATHY
KR20120062897A (ko) 2009-09-13 2012-06-14 샐릭스 파마슈티컬스 리미티드 과민성 장 증후군(ibs)의 치료방법
KR20190000931A (ko) 2009-10-27 2019-01-03 루핀 리미티드 리팍시민의 고형 분산물
MX2012005883A (es) 2009-11-23 2012-10-09 Cipla Ltd Composicion topica en espuma.
US8952159B2 (en) 2009-12-28 2015-02-10 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
WO2011103246A1 (en) 2010-02-18 2011-08-25 Salix Pharmaceuticals, Ltd. Methods for treating infection
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
EP2544660B1 (en) 2010-03-10 2018-06-13 Lupin Limited Rifaximin ready-to-use suspension
WO2012009388A1 (en) 2010-07-12 2012-01-19 Salix Pharmaceuticals, Ltd Formulations of rifaximin and uses thereof
WO2012035544A2 (en) 2010-09-13 2012-03-22 Sequent Scientific Ltd. A novel polymorphic form of rifaximin and process for its preparation
BR112013020265A2 (pt) 2011-02-11 2017-07-11 Salix Pharmaceuticals Ltd formas de rifaximina e uso das mesmas
EP2705042A1 (en) 2011-05-02 2014-03-12 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) * 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
WO2013067394A1 (en) 2011-11-02 2013-05-10 Salix Pharmaceuticals, Ltd Methods for treating irritable bowel syndrome (ibs) and infections
CA2861104A1 (en) 2012-01-25 2013-08-01 Salix Pharmaceuticals, Ltd. Rifaximin derivative and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014091432A1 (en) 2012-12-12 2014-06-19 Ranbaxy Laboratories Limited Pharmaceutical compositions of rifaximin
CN105142636A (zh) 2013-03-15 2015-12-09 意大利阿尔法韦士曼制药公司 用于治疗阴道感染的利福昔明
US20160047819A1 (en) 2013-03-15 2016-02-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
MX2015014307A (es) 2013-04-12 2015-12-08 Alfa Wassermann Spa Administracion de farmacos antiinflamatorios no esteroidales y composiciones, metodos y sistemas relacionados.
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
MX2016014329A (es) 2014-05-04 2017-02-23 Salix Pharmaceuticals Inc Microbiota ibs y sus usos.
PL3546464T3 (pl) 2014-05-12 2020-11-02 Alfasigma S.P.A. Sposób wytwarzania i zastosowanie postaci krystalicznej Tau rifaksyminy solwatowanej z DEGME
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
EP4137132A1 (en) 2016-09-30 2023-02-22 Salix Pharmaceuticals, Inc. Solid dispersion forms of rifaximin
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine
WO2019003076A1 (en) * 2017-06-26 2019-01-03 Biofer S.P.A. PYRIDO-IMIDAZO-RIFAMYCIN DERIVATIVES AS ANTIBACTERIAL AGENT

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (it) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.
CH633014A5 (en) * 1978-06-09 1982-11-15 Erba Farmitalia Rifamycin compounds

Also Published As

Publication number Publication date
FR2482967B1 (it) 1985-03-29
NO155622C (no) 1987-04-29
ATA222781A (de) 1983-06-15
FI69467B (fi) 1985-10-31
ES502906A0 (es) 1982-04-01
GB2079270B (en) 1984-01-18
ZA813430B (en) 1982-06-30
AR226212A1 (es) 1982-06-15
PH17207A (en) 1984-06-19
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
PH18704A (en) 1985-09-05
US4341785A (en) 1982-07-27
AT373599B (de) 1984-02-10
NO155622B (no) 1987-01-19
NL8102290A (nl) 1981-12-16
FR2482967A1 (fr) 1981-11-27
AU537093B2 (en) 1984-06-07
ES8203388A1 (es) 1982-04-01
PT73064A (en) 1981-06-01
GB2079270A (en) 1982-01-20
DK157876B (da) 1990-02-26
FI69467C (fi) 1986-02-10
JPS5711987A (en) 1982-01-21
DK157876C (da) 1990-07-30
NO811731L (no) 1981-11-23
DK224781A (da) 1981-11-23
NL187022C (nl) 1991-05-01
IT1154655B (it) 1987-01-21
IE51204B1 (en) 1986-10-29
DE3120460A1 (de) 1982-03-11
IE811139L (en) 1981-11-22
EG14891A (en) 1985-12-31
BE888895A (fr) 1981-09-16
LU83376A1 (fr) 1981-09-11
FI811565L (fi) 1981-11-23
SE453089B (sv) 1988-01-11
JPS6123192B2 (it) 1986-06-04
NL187022B (nl) 1990-12-03
CH648037A5 (de) 1985-02-28
GR75640B (it) 1984-08-02
DE3120460C2 (it) 1990-12-13
AU7065581A (en) 1981-11-26
CA1142518A (en) 1983-03-08

Similar Documents

Publication Publication Date Title
IT8003429A0 (it) Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
IT1141057B (it) Derivati di deformiltilosina e loro preparazione
IT8222769A0 (it) Composti tetrakisazo derivati e procedimenti per la loro preparazione ed uso
IT1130489B (it) Derivati chinonici particolarmente utili come medianti e procedimento per la loro preparazione
IT1123120B (it) Cefem derivati e procedimento per la loro preparazione
IT1164735B (it) Derivati adenosinici e procedimento per la loro preparazione
IT1164076B (it) Composti farmaceutici ad azione antiulcera e procedimento per la loro preparazione
IT7969010A0 (it) Derivati di benzotiepinici e procedimento per la loro preparazione
IT1165368B (it) Nuovi cefem derivati ad azione antimicrobica e procedimento per la loro preparazione
IT1132403B (it) Derivati di alovincamone e procedimento per la loro preparazione
IT1147741B (it) Derivati di idrossiammino eburnano e procedimento per la loro preparazione
IT1094902B (it) Composti bis-benzimidazolilici sostituiti,loro preparazione e loro uso
IT1113203B (it) Derivati steroideo-spiro-ossazolidinonici sostituiti e procedimento per la loro preparazione
IT1143701B (it) Derivati aril-idrazonici,loro uso come pesticidi e loro preparazione
IT1135629B (it) N-imidzolil derivati di 1-cromano e procedimento per la loro preparazione
IT1132404B (it) Derivati di 10-alo-e-omoeburnano e procedimento per la loro preparazione
IT1127336B (it) Derivati della cefalosporina loro preparazione e loro impiego
IT1106130B (it) Derivati di 24-deidrovitamina d3 e loro preparazione
IT1169903B (it) Derivati epossicarbaciclinici, loro preparazione e loro uso
IT1212412B (it) Derivati della benzo-as-triazina e procedimento per la loro preparazione.
IT1174735B (it) Derivati di tunicamina di attivita antibatterica e loro metodo di preparazione
IT8303354A0 (it) Derivati carbomoil-rifamicinici,metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8203360A0 (it) Nuovi derivati carbamoilrifamicinici, metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8203626A0 (it) Nuovi derivati imidazorifamicinici, metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8119566A0 (it) Derivati della prostaciclina,loro preparazione e impiego

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 46

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 46, 19920304; ALFA WASSERMANN S.P.A.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423